Harmony Biosciences Holdings (HRMY) Other financing activities (2020 - 2026)
Harmony Biosciences Holdings (HRMY) posted Other financing activities of $347000.0 for Q1 2026, down 86.9% sequentially from $2.6 million in Q4 2025, and down 92.63% YoY from $4.7 million in Q1 2025.
Harmony Biosciences Holdings (HRMY) Other financing activities (2020 - 2026) Analysis & Trends
Harmony Biosciences Holdings has reported Other financing activities for 7 years, with the latest figure at $347000.0 in Q1 2026.
- Quarterly Other financing activities fell 92.63% year-over-year to $347000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $5.8 million (down 47.29% YoY) and the FY2025 annual result came in at $10.2 million, up 56.98% from the prior year.
- Other financing activities slipped to $347000.0 in Q1 2026 per HRMY's latest filing, from $2.6 million in the prior quarter.
- Over five years, Other financing activities peaked at $4.7 million in Q1 2025 and troughed at $116000.0 in Q1 2024.
- A 5-year average of $1.8 million and a median of $1.9 million in 2022 frame the typical range for Other financing activities.
- The sharpest annual moves came in 2022 and 2024: Other financing activities jumped 15591.67% in 2022, then tumbled 97.03% in 2024.
- Over 5 years, Other financing activities stood at $3.6 million in 2022, then plunged by 93.63% to $227000.0 in 2023, then soared by 1325.99% to $3.2 million in 2024, then dropped by 18.2% to $2.6 million in 2025, then sank by 86.9% to $347000.0 in 2026.
- According to Business Quant data, Other financing activities over the past three periods registered $347000.0, $2.6 million, and $754000.0 for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn |
| 10 | Harmony Biosciences Holdings | 2.22 Bn | 1.41 Bn | 198.08 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 5.52 Mn |
| Jun 30, 2026 | 5.52 Mn |
| Mar 31, 2026 | 347,000.00 |
| Mar 31, 2026 | 347,000.00 |
| Dec 31, 2025 | 2.65 Mn |
| Dec 31, 2025 | 2.65 Mn |
| Sep 30, 2025 | 754,000.00 |
| Sep 30, 2025 | 754,000.00 |
| Jun 30, 2025 | 2.10 Mn |
| Jun 30, 2025 | 2.10 Mn |
| Mar 31, 2025 | 4.71 Mn |
| Mar 31, 2025 | 4.71 Mn |
| Dec 31, 2024 | 3.24 Mn |
| Dec 31, 2024 | 3.24 Mn |
| Sep 30, 2024 | 2.58 Mn |
| Sep 30, 2024 | 2.58 Mn |
| Jun 30, 2024 | 573,000.00 |
| Jun 30, 2024 | 573,000.00 |
| Mar 31, 2024 | 116,000.00 |
| Mar 31, 2024 | 116,000.00 |